Ecuador vs Eritrea: HIV-positive TB patients on ART (antiretroviral therapy)
Ecuador
100.0%
in 2024
Eritrea
100.0%
in 2024
Ecuador rank
1st
Eritrea rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Ecuador
- Eritrea
How they compare
Ecuador currently reports 100.0% against 100.0% in Eritrea, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2013 it was Ecuador ahead.
Ecuador ranks 1st and Eritrea ranks 1st of 144 countries.
Across the 2 decades both report, Ecuador averaged higher in 1 and Eritrea in 1.
Head to head by decade
| Decade | Ecuador | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.6% | 82.1% | 12.4% | Ecuador |
| 2020s | 93.8% | 98.2% | 4.4% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Ecuador or Eritrea?
- Ecuador, at 100.0% against 100.0% in Eritrea as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Ecuador and Eritrea?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Eritrea?
- 12 years are reported by both, from 2013 to 2024.
- How do Ecuador and Eritrea rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Ecuador ranks 1st and Eritrea ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.